Bastien Boulle is a pharmacist working with Ethypharm in Shangai.
“ETHYPHARM is a pharmaceutical company which develops oral modified release formulations through its patented technologies. It focuses on developing, manufacturing and licensing pharmaceutical products based on optimization of delivery through proprietary technologies.
Ethypharm is a French company, present on the principal world health markets with manufacturing and R & D sites in Europe, in North America and Asia. It employs 600 people worldwide. The company has a special focus on pain management, cardiovascular, oncology and CNS branded and generic products. Its know-how and dedicated plant for narcotics makes it one of the leading experts in developing and licensing controlled active substances worldwide.
Its specificity is to offer its international partners the development of key products, with a total package of services and support, through the pharmaceutical and clinical development to registration and manufacture.
Over the years, Ethypharm has developed more than 50 branded and generic products, based on its core proprietary technologies. The Group also develops scientific programs and partnerships, addressing new areas of Drug Delivery through innovative emerging technologies.”